Dimensional Fund Advisors LP Fate Therapeutics Inc Transaction History

Dimensional Fund Advisors LP

$391 Billion
Q1 2025

A detailed history of Dimensional Fund Advisors LP transactions in Fate Therapeutics Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 2,591,558 shares of FATE stock, worth $3.24 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,591,558

Previous 2,898,377 10.59%

Holding current value

$3.24 Million

Previous $4.78 Million 57.19%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	SELL	$0.79 - $1.87 $242,387 - $573,751	-306,819 Reduced 10.59%	2,591,558 $2.05 Million
Q4 2024 Feb 13, 2025	BUY	$1.61 - $3.35 $449,769 - $935,856	279,360 Added 10.67%	2,898,377 $4.78 Million
Q3 2024 Nov 07, 2024	BUY	$3.12 - $5.57 $1.52 Million - $2.72 Million	488,737 Added 22.94%	2,619,017 $9.17 Million
Q2 2024 Aug 09, 2024	BUY	$3.26 - $7.08 $3.48 Million - $7.56 Million	1,067,101 Added 100.37%	2,130,280 $6.99 Million
Q1 2024 May 10, 2024	BUY	$3.54 - $8.35 $2.63 Million - $6.2 Million	742,405 Added 231.44%	1,063,179 $7.8 Million
Q4 2023 Feb 07, 2024	SELL	$1.65 - $3.94 $650,718 - $1.55 Million	-394,375 Reduced 55.15%	320,774 $1.2 Million
Q3 2023 Nov 09, 2023	BUY	$2.02 - $5.04 $1.03 Million - $2.57 Million	510,423 Added 249.32%	715,149 $1.52 Million
Q2 2023 Aug 09, 2023	SELL	$4.76 - $6.59 $689,262 - $954,251	-144,803 Reduced 41.43%	204,726 $974,000
Q1 2023 May 12, 2023	SELL	$4.24 - $11.12 $856,225 - $2.25 Million	-201,940 Reduced 36.62%	349,529 $1.99 Million
Q4 2022 Feb 09, 2023	BUY	$9.86 - $23.83 $3.07 Million - $7.43 Million	311,787 Added 130.08%	551,469 $5.56 Million
Q3 2022 Nov 10, 2022	SELL	$21.04 - $36.06 $578,263 - $991,073	-27,484 Reduced 10.29%	239,682 $5.37 Million
Q2 2022 Aug 12, 2022	SELL	$17.78 - $42.39 $2.17 Million - $5.17 Million	-121,950 Reduced 31.34%	267,166 $6.62 Million
Q1 2022 May 13, 2022	SELL	$29.67 - $60.28 $752,460 - $1.53 Million	-25,361 Reduced 6.12%	389,116 $15.1 Million
Q4 2021 Feb 09, 2022	BUY	$47.84 - $64.34 $4.56 Million - $6.14 Million	95,408 Added 29.9%	414,477 $24.3 Million
Q3 2021 Nov 12, 2021	BUY	$59.27 - $95.73 $11.3 Million - $18.3 Million	191,004 Added 149.15%	319,069 $18.9 Million
Q2 2021 Aug 12, 2021	BUY	$67.25 - $92.52 $4.26 Million - $5.86 Million	63,303 Added 97.75%	128,065 $11.1 Million
Q1 2021 May 14, 2021	BUY	$72.16 - $117.4 $2.34 Million - $3.8 Million	32,404 Added 100.14%	64,762 $5.36 Million
Q4 2020 Feb 25, 2021	BUY	$38.09 - $100.95 $1.23 Million - $3.27 Million	32,358 New	32,358 $2.94 Million

Others Institutions Holding FATE

# of Institutions

146

Shares Held

96.9M

Call Options Held

56.7K

Put Options Held

5.4K

View Full List

About FATE THERAPEUTICS INC

Ticker FATE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,000,304
Market Cap $121M
Description
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Its NK- and T-cell immuno-oncology programs under development include FT516 for the treatment of acute myeloid leukemia (AML) B-cell lymphoma, and advanced solid tumor; FT596 to treat B-cell...

More about FATE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.

Account

Dimensional Fund Advisors LP Fate Therapeutics Inc Transaction History